Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Moderna Inc (MRNA)

Moderna Inc (MRNA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 27,856,650
  • Shares Outstanding, K 371,224
  • Annual Sales, $ 60,210 K
  • Annual Income, $ -514,020 K
  • 60-Month Beta 0.67
  • Price/Sales 442.57
  • Price/Cash Flow N/A
  • Price/Book 14.39

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 12 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/20
See More
  • Average Estimate -0.40
  • Number of Estimates 5
  • High Estimate -0.33
  • Low Estimate -0.58
  • Prior Year -0.41
  • Growth Rate Est. (year over year) +2.44%

Price Performance

See More
Period Period Low Period High Performance
1-Month
55.81 +43.74%
on 07/02/20
88.37 -9.22%
on 07/15/20
+13.65 (+20.50%)
since 06/15/20
3-Month
36.62 +119.06%
on 04/16/20
88.37 -9.22%
on 07/15/20
+42.97 (+115.36%)
since 04/15/20
52-Week
11.54 +595.15%
on 08/07/19
88.37 -9.22%
on 07/15/20
+65.90 (+460.20%)
since 07/15/19

Most Recent Stories

More News
Moderna, Waters rise; ASML Holding falls

NEW YORK (AP) — Stocks that moved heavily or traded substantially on Wednesday:

MRNA : 80.22 (+6.90%)
FANG : 39.90 (+1.58%)
PVH : 50.78 (+9.18%)
WAT : 220.80 (+11.48%)
SIRI : 6.01 (+6.18%)
Moderna Inches Closer to Coronavirus Vaccine: ETFs to Shine

Moderna plans to begin the Phase 3 study of mRNA-1273 this month.

PFE : 35.72 (+1.39%)
MRNA : 80.22 (+6.90%)
IBB : 142.62 (+1.68%)
CNCR : 27.53 (+3.11%)
XBI : 117.24 (+2.13%)
BBH : 172.76 (+1.43%)
FBT : 176.06 (+2.05%)
BTEC : 47.38 (+3.48%)
IDNA : 40.22 (+2.65%)
GERM : 31.60 (+0.90%)
How to Tap Red-Hot Moderna Stock With ETFs

Moderna shares have surged more than 280% so far this year on the positive development of coronavirus vaccine.

MRNA : 80.22 (+6.90%)
IBB : 142.62 (+1.68%)
CNCR : 27.53 (+3.11%)
XBI : 117.24 (+2.13%)
BBH : 172.76 (+1.43%)
BTEC : 47.38 (+3.48%)
IDNA : 40.22 (+2.65%)
GERM : 31.60 (+0.90%)
Q2 Earnings in Focus

Q2 Earnings in Focus

JPM : 99.73 (+1.55%)
UNH : 304.07 (-1.44%)
GS : 216.90 (+1.35%)
C : 51.84 (+3.37%)
AZN : 58.00 (+7.45%)
CCL : 17.48 (+16.22%)
MRNA : 80.22 (+6.90%)
UAL : 36.37 (+14.59%)
Goldman Boosts Dow with Best Quarter in Years

Goldman simply blew the doors off Q2 expectations, posting $6.26 per share on $13.3 billion in quarterly revenues which compare very favorably with the $3.97 per share and $10.07 billion in the Zacks consensus....

JPM : 99.73 (+1.55%)
UNH : 304.07 (-1.44%)
GS : 216.90 (+1.35%)
C : 51.84 (+3.37%)
AZN : 58.00 (+7.45%)
CCL : 17.48 (+16.22%)
MRNA : 80.22 (+6.90%)
UAL : 36.37 (+14.59%)
Company News for Jul 15, 2020

Companies in the news are: WIT, FRC, FAST, MRNA

FAST : 44.02 (+1.43%)
MRNA : 80.22 (+6.90%)
WIT : 3.85 (+10.32%)
FRC : 111.08 (+2.17%)
Moderna Rallies on Encouraging Coronavirus Vaccine Study Data

Moderna's (MRNA) coronavirus vaccine candidate achieves levels of antibodies similar or higher than those typically found in a patient who recovered from COVID-19 naturally.

JNJ : 148.26 (+0.23%)
PFE : 35.72 (+1.39%)
MRNA : 80.22 (+6.90%)
BNTX : 78.00 (-7.01%)
Distancing Measures Force Innovations in Patient Monitoring Procedures

, /PRNewswire/ -- The current pandemic has created the need for new technologies in order to improve population-level screening and patient monitoring. One sector that has emerged in recent years and...

NMRD : 9.48 (+18.95%)
VXRT : 14.49 (-14.61%)
MRNA : 80.22 (+6.90%)
GILD : 76.65 (-0.70%)
INO : 24.51 (-6.49%)
The Zacks Analyst Blog Highlights: Pfizer, BioNTech, Moderna, Novavax and Johnson & Johnson

The Zacks Analyst Blog Highlights: Pfizer, BioNTech, Moderna, Novavax and Johnson & Johnson

JNJ : 148.26 (+0.23%)
PFE : 35.72 (+1.39%)
MRNA : 80.22 (+6.90%)
NVAX : 111.15 (+1.07%)
BNTX : 78.00 (-7.01%)
Expect Further Rally in Nasdaq-100 ETFs as Moderna Joins

Moderna shares have gained a whopping 283.6% this year due to successful early-stage clinical trials for COVID-19 vaccine, winning a place on the Nasdaq-100 with the company's sheer success.

MRNA : 80.22 (+6.90%)
QQQ : 260.90 (+0.20%)
BBH : 172.76 (+1.43%)
QQEW : 82.93 (+0.96%)
TQQQ : 113.76 (+0.49%)
IPO : 43.18 (+1.24%)
BTEC : 47.38 (+3.48%)
GERM : 31.60 (+0.90%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade MRNA with:

Business Summary

Moderna Inc. is a clinical stage biotechnology company pioneering messenger RNA therapeutics and vaccines for patients. The company's product pipeline which is in clinical stage consists of mRNA-1647 for Cytomegalovirus Infectious Disease, mRNA-4157 for Solid tumors, mRNA-2416 for lymphoma and mRNA-...

See More

Key Turning Points

2nd Resistance Point 92.56
1st Resistance Point 86.39
Last Price 80.22
1st Support Level 76.03
2nd Support Level 71.84

See More

52-Week High 88.37
Last Price 80.22
Fibonacci 61.8% 59.02
Fibonacci 50% 49.96
Fibonacci 38.2% 40.89
52-Week Low 11.54

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar